Patriot Financial Group Insurance Agency’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,950
Closed -$10.6K 495
2022
Q4
$10.6K Buy
11,950
+98
+0.8% +$130 ﹤0.01% 429
2022
Q3
$19K Sell
11,852
-5,700
-32% -$12.9K ﹤0.01% 396
2022
Q2
$35K Sell
17,552
-77,700
-82% -$134K 0.01% 850
2022
Q1
$222K Buy
95,252
+12,950
+16% +$40.4K 0.04% 391
2021
Q4
$383K Buy
82,302
+35,650
+76% +$221K 0.06% 294
2021
Q3
$356K Buy
46,652
+450
+1% +$3.82K 0.06% 302
2021
Q2
$448K Buy
46,202
+24,050
+109% +$192K 0.08% 249
2021
Q1
$183K Buy
22,152
+13,300
+150% +$140K 0.04% 411
2020
Q4
$60K Buy
8,852
+1,650
+23% +$13.3K 0.02% 639
2020
Q3
$80K Buy
7,202
+3,300
+85% +$30.2K 0.03% 443
2020
Q2
$25K Buy
+3,902
New +$14.9K 0.01% 694

Other funds holding SRNE

Patriot Financial Group Insurance Agency's SRNE Position: Q1 2023 in Review

Patriot Financial Group Insurance Agency sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 11,950 shares — an estimated $10.6K sold.

Patriot Financial Group Insurance Agency first reported a position in SRNE in Q2 2020 and held it in 11 quarters. The position peaked at $448K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Patriot Financial Group Insurance Agency reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 11,950 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $10.6K.
  • Patriot Financial Group Insurance Agency first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 11 quarters.
  • Patriot Financial Group Insurance Agency's Sorrento Therapeutics, Inc. position peaked at $448K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2023, filed 20 Apr 2023.